Completed PHASE3 INTERVENTIONAL 1-arm NCT00135122

Prednisolone in the Treatment of Withdrawal Headache in Probable Medication Overuse Headache

Medication Overuse Headache: A Randomised Double Blind Study of Prednisolone or Placebo in Withdrawal Therapy (Phase 3), and a Randomised 1 Year Follow up by Neurologist or General Physician After Successful Withdrawal Therapy

Sponsor: Sorlandet Hospital HF

Conditions Headache

Interventions prednisolone

Updated 5 times since 2017 Last updated: Sep 11, 2008 Started: Sep 30, 2003 Primary completion: Jan 31, 2007 Completion: Jan 31, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00135122, this PHASE3 trial focuses on Headache and remains completed. Sponsored by Sorlandet Hospital HF, it has been updated 5 times since 2003, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Sep 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Sorlandet Hospital HF

Data source: Sorlandet Hospital HF

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Kristiansand, Norway